Literature DB >> 16517752

Preprotachykinin-A gene products are key mediators of lung injury in polymicrobial sepsis.

Padmam Puneet1, Akhil Hegde, Siaw Wei Ng, Hon Yen Lau, Jia Lu, Shabbir M Moochhala, Madhav Bhatia.   

Abstract

Preprotachykinin-A (PPT-A) gene products substance P and neurokinin-A have been shown to play an important role in neurogenic inflammation. To investigate the role of PPT-A gene products in lung injury in sepsis, polymicrobial sepsis was induced by cecal ligation and puncture in PPT-A gene-deficient mice (PPT-A(-/-)) and the wild-type control mice (PPT-A(+/+)). PPT-A gene deletion significantly protected against mortality, delayed the onset of lethality, and improved the long-term survival following cecal ligation and puncture-induced sepsis. PPT-A(-/-) mice also had significantly attenuated inflammation and damage in the lungs. The data suggest that deletion of the PPT-A gene may have contributed to the disruption in recruitment of inflammatory cells resulting in protection against tissue damage, as in these mice the sepsis-associated increase in chemokine levels is significantly attenuated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517752     DOI: 10.4049/jimmunol.176.6.3813

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Substance P in polymicrobial sepsis: molecular fingerprint of lung injury in preprotachykinin-A-/- mice.

Authors:  Akhil Hegde; Ramasamy Tamizhselvi; Jayapal Manikandan; Alirio J Melendez; Shabbir M Moochhala; Madhav Bhatia
Journal:  Mol Med       Date:  2010-02-08       Impact factor: 6.354

2.  Substance P receptor blockade decreases stretch-induced lung cytokines and lung injury in rats.

Authors:  Fabienne Brégeon; Jean Guillaume Steinberg; Nicolas Andreotti; Jean-Marc Sabatier; Stéphane Delpierre; Sylvie Ravailhe; Yves Jammes
Journal:  J Physiol       Date:  2010-02-22       Impact factor: 5.182

Review 3.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease.

Authors:  Martin S Steinhoff; Bengt von Mentzer; Pierangelo Geppetti; Charalabos Pothoulakis; Nigel W Bunnett
Journal:  Physiol Rev       Date:  2014-01       Impact factor: 37.312

4.  Antagonism of the Neurokinin-1 Receptor Improves Survival in a Mouse Model of Sepsis by Decreasing Inflammation and Increasing Early Cardiovascular Function.

Authors:  Juan R Mella; Evan Chiswick; David Stepien; Rituparna Moitra; Elizabeth R Duffy; Arthur Stucchi; Daniel Remick
Journal:  Crit Care Med       Date:  2017-02       Impact factor: 7.598

5.  Contributions of TRPV1, endovanilloids, and endoplasmic reticulum stress in lung cell death in vitro and lung injury.

Authors:  Karen C Thomas; Jessica K Roberts; Cassandra E Deering-Rice; Erin G Romero; Randal O Dull; Jeewoo Lee; Garold S Yost; Christopher A Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-23       Impact factor: 5.464

6.  Neurokinin-1 Receptor Deficiency Improves Survival in Murine Polymicrobial Sepsis Through Multiple Mechanisms in Aged Mice.

Authors:  Juan R Mella; Arthur F Stucchi; Elizabeth R Duffy; Daniel G Remick
Journal:  Shock       Date:  2019-07       Impact factor: 3.454

Review 7.  TRPV1 and SP: key elements for sepsis outcome?

Authors:  Jennifer Victoria Bodkin; Elizabeth Soares Fernandes
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

8.  Inhaled nitric oxide prevents 3-nitrotyrosine formation in the lungs of neonatal mice exposed to >95% oxygen.

Authors:  Michael R Stenger; Melissa J Rose; Mandar S Joshi; Lynette K Rogers; Louis G Chicoine; John Anthony Bauer; Leif D Nelin
Journal:  Lung       Date:  2010-03-17       Impact factor: 2.584

9.  Plasma cytokine profiles in preprotachykinin-A knockout mice subjected to polymicrobial sepsis.

Authors:  Akhil Hegde; Mahesh Uttamchandani; Shabbir M Moochhala; Madhav Bhatia
Journal:  Mol Med       Date:  2009-10-29       Impact factor: 6.354

10.  Substance P mediates reduced pneumonia rates after traumatic brain injury.

Authors:  Sung Yang; David Stepien; Dennis Hanseman; Bryce Robinson; Michael D Goodman; Timothy A Pritts; Charles C Caldwell; Daniel G Remick; Alex B Lentsch
Journal:  Crit Care Med       Date:  2014-09       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.